J. Schiffenbauer

发表

Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box.

D. K. Didier, J. Schiffenbauer, S. Woulfe, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis

J. Soos, J. Schiffenbauer, H. Johnson, 1993, Journal of Neuroimmunology.

Aberrant Expression of the NF-κB and IκB Proteins in B Cells from Viable Motheaten Mice

A. Khaled, J. Schiffenbauer, E. Sobel, 1999 .

Intrinsic Property of B Cells in Haplotype-Heterozygous Mice Is an-Induced Autoimmunity 2 Resistance to HgCl

G. Hanley, J. Schiffenbauer, E. Sobel, 1998 .

Resistance to HgCl2-induced autoimmunity in haplotype-heterozygous mice is an intrinsic property of B cells.

G. Hanley, J. Schiffenbauer, E. Sobel, 1998, Journal of immunology.

Serial pulmonary function testing in patients with systemic lupus erythematosus.

P. Eichacker, A. Grayzel, J. Schiffenbauer, 1988, Chest.

Class II haplotype differentially regulates immune response in HgCl2-treated mice.

G. Hanley, J. Schiffenbauer, E. Sobel, 1997, Clinical immunology and immunopathology.

Mixed haplotypes and autoimmunity.

D. McCarthy, J. Schiffenbauer, B. Schwartz, 1993, Immunology today.

Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells.

C. Mohan, E. Wakeland, L. Morel, 1999, Journal of immunology.

The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor.

M. Labow, L. Moldawer, W. Streit, 2000, Clinical immunology.

Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B.

A. Khaled, J. Schiffenbauer, E. Sobel, 1998, Cellular immunology.

Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function.

A. Khaled, J. Schiffenbauer, E. Sobel, 1998, Clinical immunology and immunopathology.

Superantigens and their role in autoimmune disorders.

J. Schiffenbauer, 1999, Archivum immunologiae et therapiae experimentalis.

The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders.

J. Soos, J. Schiffenbauer, H. Johnson, 1998, Immunology today.

Cloning of a cDNA Encoding Class II Specific DNA Binding Protein

D. K. Didier, J. Schiffenbauer, S. Woulfe, 1989 .

Inhibition of the p50 (NFκB1) Subunit of NF-κB by Phosphorothioate-Modified Antisense Oligodeoxynucleotides Reduces NF-κB Expression and Immunoglobulin Synthesis in Murine B Cells

A. Khaled, I. Stekman, J. Schiffenbauer, 1997 .

Inhibition of the p50 (NKkappaB1) subunit of NF-kappaB by phosphorothioate-modified antisense oligodeoxynucleotides reduces NF-kappaB expression and immunoglobulin synthesis in murine B cells.

A. Khaled, I. Stekman, J. Schiffenbauer, 1997, Clinical immunology and immunopathology.

Sequence of a DPβ cDNA from the DR5, DQw7, DPw4b Cell Line Swei

D. K. Didier, J. Schiffenbauer, S. Woulfe, 1989 .

Evidence for heterogeneity of the DPA and DPB alleles derived from a DRw11,DQw7,DPw4 cell line.

M. Farrar, D. K. Didier, J. Schiffenbauer, 1989, Human immunology.

The molecules recognized by anti-MT2 alloantisera and anti-MT2-like (DRw52) monoclonal antibodies are different.

J. Schiffenbauer, B. Schwartz, C. Bono, 1985, Human immunology.

Multiple mechanisms produce diversity of HLA-C alleles.

C. Lutz, D. K. Didier, J. Schiffenbauer, 1990, Human immunology.

Genetic Dissection of Systemic Lupus Erythematosus Pathogenesis: Evidence for Functional Expression of Sle3/5 by Non-T Cells1

C. Mohan, E. Wakeland, L. Morel, 2002, The Journal of Immunology.

Bone Marrow-Derived B Mediates the Loss Sle 1 Adoptive Transfer of Genetic Dissection of SLE Pathogenesis : Schiffenbauer

C. Mohan, E. Wakeland, L. Morel, 1999 .

Characterization of two distinct DR beta chain alleles at the beta III locus of the DR5 haplotype: beta III alleles are highly conserved.

J. Gorski, D. K. Didier, J. Schiffenbauer, 1986, Journal of immunology.

A unique sequence of the NZW I-E beta chain and its possible contribution to autoimmunity in the (NZB x NZW)F1 mouse

D. McCarthy, D. K. Didier, J. Schiffenbauer, 1989, The Journal of experimental medicine.

Background genes mediate the development of autoimmunity in (NZB x PL/J)F1 or (NZB x BIO.PL)F1 mice.

B. Croker, J. Schiffenbauer, L. Wegrzyn, 1992, Clinical immunology and immunopathology.

Resistance to HgCl

J. Schiffenbauer, E. Sobel, Greg Hanley, 1998 .

Newer lymphocyte surface antigens

J. Schiffenbauer, B. Schwartz, Benjamin D. Schwartz, 1984, Survey of immunologic research.

Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box ( HLA / gene regulation )

D. K. Didier, J. Schiffenbauer, S. Woulfe, 2022 .

Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras.

R. Eisenberg, J. Schiffenbauer, P. Cohen, 1998, Journal of immunology.

This information is current as-+ Mixed Chimeras lpr Revealed by Novel Immunoregulatory B Cell Pathways

R. Eisenberg, J. Schiffenbauer, P. Cohen, 1998 .

Interleukin-2 gene deletion produces a robust reduction in susceptibility to experimental autoimmune encephalomyelitis in C57BL/6 mice

W. Streit, J. Schiffenbauer, J. Petitto, 2000, Neuroscience Letters.

Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.

J. Soos, J. Schiffenbauer, H. Johnson, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Sequence of class II major histocompatibility complex genes from MRL mice. Conserved amino acids in the I-E beta chains from autoimmune mice.

J. Schiffenbauer, L. Wegrzyn, 2010, Arthritis and rheumatism.

Prevention of experimental allergic encephalomyelitis by an antibody to CD45RB.

W. Streit, G. Hanley, J. Schiffenbauer, 1998, Cellular immunology.

Use of monoclonal antibodies to identify shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus.

B. Diamond, G. Solomon, J. Schiffenbauer, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Intramolecular epitope spreading induced by staphylococcal enterotoxin superantigen reactivation of experimental allergic encephalomyelitis

J. Soos, J. Schiffenbauer, H. Johnson, 2002, Journal of Neuroimmunology.

Polygenic control of susceptibility to murine systemic lupus erythematosus.

E. Wakeland, L. Morel, J. Schiffenbauer, 1994, Immunity.

The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity.

P. Subramaniam, J. Soos, J. Schiffenbauer, 1995, Journal of immunology.

Complete sequence of the HLA Dqa and DQb cDNA from a DR5/DQw3 cell line

D. K. Didier, J. Schiffenbauer, B. Schwartz, 1991, The Journal of Immunology.

Complete sequence of the HLA DQ alpha and DQ beta cDNA from a DR5/DQw3 cell line.

D. K. Didier, J. Schiffenbauer, B. Schwartz, 1987, Journal of immunology.

Detection of masked anti-DNA antibodies in lupus sera by a monoclonal anti-idiotype.

B. Diamond, G. Solomon, J. Schiffenbauer, 1984, Journal of immunology.

Multiplex inheritance of component phenotypes in a murine model of lupus

C. Mohan, E. Wakeland, L. Morel, 1999, Mammalian Genome.

Superantigens as virulence factors in autoimmunity and immunodeficiency diseases.

J. Soos, J. Schiffenbauer, H. Johnson, 1997, Medical hypotheses.

Hyperproliferation of BXSB B cells is linked to the Yaa allele.

J. Schiffenbauer, E. Sobel, E. Butfiloski, 1996, Clinical immunology and immunopathology.

Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis.

J. Soos, J. Schiffenbauer, H. Johnson, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Acceleration of Autoimmunity by Organochlorine Pesticides in (NZB × NZW)F1 Mice

B. Croker, S. Roberts, John Gianini, 2004, Environmental health perspectives.

Biomarkers, surrogate markers, and design of clinical trials of new therapies for systemic lupus erythematosus.

M. Weisman, L. Simon, B. Hahn, 2004, Arthritis and rheumatism.

Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?

L. Simon, J. Schiffenbauer, 2004, Lupus.

Reflex sympathetic dystrophy involving multiple extremities.

J. Schiffenbauer, M. Fagien, 1993, The Journal of rheumatology.